Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Dec 06, 2021 2:45pm
119 Views
Post# 34203248

RE:Reject from NASDAQ

RE:Reject from NASDAQ

4justice

This plan has been the master plan for a long time. Looking back how everything unfolded, Thomvest had the plan, financial engineering techniques and control of management every press release. The May press release on shelving lead indications of 4050 took all business milestones off the table after Ryplazim was sold. Thomvest want to create perception that 4050 is worthless and that they were fooled as well. They get tax loss, IP and perception that everything was worthless for the lawsuit so they were fooled, too. Moran and Gagnon should have something to say about value of 4050 when facts come out


4Justice wrote: If you think about what's going on, you should conclude that the best outcome for the Thomson family, their financial arm Thomvest and their tax free company SALP is to be rejected from the NASDAQ and becoming private. They will buy back minority shareholders at a very low price and keep the IPs for themselves....



 

<< Previous
Bullboard Posts
Next >>